COVID-19 immune response strengthens over time Oregon Health & Science University (OHSU) researchers found that the more time between vaccination and infection, the greater the strength of the immunity from COVID-19. The findings, published on Thursday in the Journal for Clinical Investigation Insight, suggest that people who’ve had COVID-19 can benefit from vaccination, even if they’ve delayed it.Read More
Grey Wolf Therapeutics nabs $49M in Series B financing Grey Wolf Therapeutics, a biotech firm focused on generating antitumor immune responses through targeted cancer neoantigen creation, last week announced the closing of an oversubscribed $49 million Series B financing.Read More
Atomic AI closes $35M Series A financing Biotech firm Atomic AI recently announced it the closing of a $35 million Series A round led by Playground Global, with participation from 8VC, Factory HQ, Greylock, NotBoring, AME Cloud Ventures, GitHub’s ex-CEO Nat Friedman, Doug Mohr, Curai CEO Neal Khosla, and UC Berkeley Professor and Arc Institute co-founder Patrick Hsu.Read More
EMR screening program identifies prevalent undiagnosed diabetes An electronic medical record (EMR) diabetes screening program in an urban emergency department identified the prevalence of undiagnosed diabetes. The report, published on January 26 in JAMA Network Open, underscored long-existing disparities in type 2 diabetes diagnosis and treatment by race, ethnicity, and socioeconomic factors. Such disparities increased during the COVID-19 pandemic.Read More
AI tool makes speedy gene editing possible Researchers have designed an artificial intelligence (AI) program that may enable the production of customizable proteins called zinc fingers to treat diseases by turning genes on and off. The research published on January 26 in Nature Biotechnology may accelerate large-scale gene therapy development.Read More
CVD deaths undergo largest single-year increase since 2015 The American Heart Association's report "Heart Disease and Stroke Statistics—2023 Update" outlines the most significant single-year increase in cardiovascular disease (CVD) deaths in the U.S. since 2015.Read More
New probe measures cell stiffness and traction University of Illinois scientists have developed a tiny mechanical probe that can measure the inherent stiffness of cells and tissues, as well as the internal forces that cells generate and exert upon one another. It is the first probe able to quantify both properties, according to its developers.Read More